Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$143.62
2.832.01%
Last update: Oct 7, 1:34 PM
$143.12
2.331.65%
Novartis AG (NVS) Stock Price, Quote, News & History
NVSNYSE
Novartis develops and manufactures innovative drugs. Key areas of drug development are oncology, immunology, neuroscience, and cardiovascular, renal, and metabolic. It also has an established medicines business, which includes off-patent franchises....
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Novartis (NYSE:NVS) through any online brokerage.
Other companies in Novartis’s space includes: Eli Lilly and Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), Merck & Co Inc (NYSE:MRK), AstraZeneca PLC (NYSE:AZN) and Novo Nordisk AS (NYSE:NVO).
Novartis has a consensus price target of $134.80.
The stock price for Novartis (NYSE: NVS) is $143.6241 last updated October 7, 2026 at 1:34 PM EDT.
There are no upcoming dividends for Novartis.
Novartis does not have any upcoming earnings scheduled.
There is no upcoming split for Novartis.
Novartis is in the Health Care sector and Pharmaceuticals industry. They are listed on the NYSE.
